Back to discover
Drug

Nesiritide

In clinical development
Emerging researchLate-stage development
Also known as B-type natriuretic peptide, BNP, BNP-32, Brain natriuretic peptide+6 more

B-type natriuretic peptide, BNP, BNP-32, Brain natriuretic peptide, Brain natriuretic peptide 32, Human brain natriuretic factor-32, Natrecor, Natriuretic peptide B Type, Nesiritide (E. coli), nesiritide (hBNP).

RxNorm19666UNIIP7WI8UL647
3
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Clinical trial2024-12-01Terminated · ClinicalTrials.gov

Therapeutic Effects of BNP in Hypertensive Patients

Clinical trial2018-12-01Primary completion · ClinicalTrials.gov

Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis

Clinical trial2018-07-11Completed · ClinicalTrials.gov

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Clinical trial2017-02-28Completed · ClinicalTrials.gov

Natriuretic Peptides and Metabolic Risk in Obesity

Clinical trial2017-02-01Withdrawn · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Nesiritide
Aliases & brands
B-type natriuretic peptideBNPBNP-32Brain natriuretic peptideBrain natriuretic peptide 32Human brain natriuretic factor-32NatrecorNatriuretic peptide B TypeNesiritide (E. coli)nesiritide (hBNP)
RxNorm CUI
19666
UNII
P7WI8UL647

Clinical trials

52 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
52
registered trials across all phases
LATEST COMPLETION 2019
1
Active studies
1
Recruiting
30
Late-stage (III+)
30
Completed
21
Discontinued
PHASE DISTRIBUTIONn = 52
Early Phase 11Phase 14Phase 1 / 210Phase 27Phase 312Phase 410Phase N / A8

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19992011
Journals, researchers & institutions
Top journals
  • Circulation. Heart failure1
  • Journal of cardiac failure1
  • Journal of the American College of Cardiology1
Leading researchers
  • Chew E2
  • Chow SL2
  • Heywood JT2
  • O'Barr SA2
  • Pak F2
  • Patel P2
  • Patterson JH2
  • Peng J2
Leading institutions
free-text, unnormalised
  • College of Pharmacy2
  • University of Florida1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials